Cargando…
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior
Despite being overexpressed in different tumor entities, RIO kinases are hardly characterized in mammalian cells. We investigated the role of these atypical kinases in different cancer cells. Using isogenic colon-, breast- and lung cancer cell lines, we demonstrate that knockdown of RIOK1, but not o...
Autores principales: | Weinberg, Florian, Reischmann, Nadine, Fauth, Lisa, Taromi, Sanaz, Mastroianni, Justin, Köhler, Martin, Halbach, Sebastian, Becker, Andrea C., Deng, Niantao, Schmitz, Tatjana, Uhl, Franziska Maria, Herbener, Nicola, Riedel, Bianca, Beier, Fabian, Swarbrick, Alexander, Lassmann, Silke, Dengjel, Jörn, Zeiser, Robert, Brummer, Tilman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478185/ https://www.ncbi.nlm.nih.gov/pubmed/28499923 http://dx.doi.org/10.1016/j.ebiom.2017.04.015 |
Ejemplares similares
-
First Evidence of Function for Schistosoma japonicum
riok-1 and RIOK-1
por: Mughal, Mudassar N., et al.
Publicado: (2021) -
Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016) -
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
por: Halbach, Sebastian, et al.
Publicado: (2013) -
RIOK3 keeps MDA5 inactive
por: Takashima, Ken, et al.
Publicado: (2015) -
Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia
por: Sies, Katharina, et al.
Publicado: (2019)